Low-dose levonorgestrel intrauterine systems (LNG-IUS)
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 23/100
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hormonal Intrauterine Contraception
Conditions
Hormonal Intrauterine Contraception
Trial Timeline
Feb 21, 2021 → May 4, 2023
NCT ID
NCT04785950About Low-dose levonorgestrel intrauterine systems (LNG-IUS)
Low-dose levonorgestrel intrauterine systems (LNG-IUS) is a pre-clinical stage product being developed by Bayer for Hormonal Intrauterine Contraception. The current trial status is completed. This product is registered under clinical trial identifier NCT04785950. Target conditions include Hormonal Intrauterine Contraception.
What happened to similar drugs?
1 of 1 similar drugs in Hormonal Intrauterine Contraception were approved
Approved (1) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
3
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04785950 | Pre-clinical | Completed |
Competing Products
2 competing products in Hormonal Intrauterine Contraception